Literature DB >> 13089681

Some observations on the pathogenicity of isoniazid-resistant variants of tubercle bacilli.

G MIDDLEBROOK, M L COHN.   

Abstract

Entities:  

Keywords:  MYCOBACTERIUM TUBERCULOSIS/effect of drugs on; NICOTINIC ACID ISOMERS/effects

Mesh：

Substances：

Year:  1953        PMID： 13089681     DOI： 10.1126/science.118.3063.297

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  50 in total

Review 1.  Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance.

Authors:  José L Martínez; Fernando Baquero
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

2.  Growth characteristics, virulence, and cytochemical properties of tubercle bacilli recovered from patients treated with isoniazid.

Authors:  R A PATNODE; M C DAIL; P C HUDGINS
Journal:  Am J Public Health Nations Health       Date:  1955-04

3.  The clinical significance of positive cultures and of isoniazid-resistant tubercle bacilli during the treatment of pulmonary tuberculosis; report to the Tuberculosis Chemotherapy Trials Committee of the Medical Research Council.

Authors:  W FOX; I SUTHERLAND
Journal:  Thorax       Date:  1955-06       Impact factor: 9.139

4.  Mycobacterium tuberculosis: a study of the virulence of an isoniazid-resistant variant.

Authors:  R GOULDING
Journal:  Br J Exp Pathol       Date:  1955-12

5.  Antimicrobial susceptibility and some other properties of photochromogenic Mycobacteria associated with pulmonary disease.

Authors:  A MANTEN
Journal:  Antonie Van Leeuwenhoek       Date:  1957       Impact factor: 2.271

6.  Observations on the effect of isoniazid and streptomycin on tubercles in a transparent chamber in the rabbit's ear.

Authors:  L F DODSON; A G SANDERS; H W FLOREY
Journal:  Br J Exp Pathol       Date:  1955-06

7.  CHANGES in isoniazid resistance of tubercle bacilli after cessation of treatment; report by the Laboratory Subcommittee of the Tuberculosis Chemotherapy Trials Committee, Medical Research Council; M.R.C. isoniazid trial: Report No. 6.

Authors: 
Journal:  Thorax       Date:  1954-12       Impact factor: 9.139

8.  Laboratory aspects of tuberculosis in the ambulatory patient.

Authors:  D WIDELOCK; A B ROBINS
Journal:  Am J Public Health Nations Health       Date:  1954-06

9.  Genetic studies on microbial cross resistance to toxic agents. IV. Cross resistance of Bacillus megaterium to forty-four antimicrobial drugs.

Authors:  W SZYBALSKI
Journal:  Appl Microbiol       Date:  1954-03

10.  Prospective study of drug-resistant tuberculosis in a Spanish urban population including patients at risk for HIV infection.

Authors:  V Ausina; N Riutort; B Viñado; J M Manterola; J Ruiz Manzano; C Rodrigo; L Matas; M Giménez; J Tor; J Roca
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-02       Impact factor: 3.267
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.